Overview

Simvastatin Treatment of Patients With Acute Optic Neuritis

Status:
Unknown status
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate if the simvastatin treatment improve the visual function after 3 months of the inclusion to this project and if the simvastatin influences the results on cerebral MRI after 3 and 6 months of the inclusion. In addition the development of new demyelinating relapses. In the patients with monosymptomatic acut optic neuritis to investigate whether the simvastatin reduces the risk to develop multiple sclerosis (MS).
Phase:
Phase 3
Details
Lead Sponsor:
Glostrup University Hospital, Copenhagen
Collaborator:
Alpharma ApS
Treatments:
Simvastatin